- Home
- IDAI vs XXII Comparison
IDAI vs XXII Comparison
Compare IDAI & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDAI
- XXII
- Stock Information
- Founded
- IDAI 2016
- XXII 1998
- Country
- IDAI United States
- XXII United States
- Employees
- IDAI N/A
- XXII N/A
- Industry
- IDAI Computer Software: Prepackaged Software
- XXII Medicinal Chemicals and Botanical Products
- Sector
- IDAI Technology
- XXII Health Care
- Exchange
- IDAI Nasdaq
- XXII Nasdaq
- Market Cap
- IDAI 7.7M
- XXII 6.2M
- IPO Year
- IDAI N/A
- XXII N/A
- Fundamental
- Price
- IDAI $3.64
- XXII $1.55
- Analyst Decision
- IDAI Strong Buy
- XXII
- Analyst Count
- IDAI 1
- XXII 0
- Target Price
- IDAI $12.00
- XXII N/A
- AVG Volume (30 Days)
- IDAI 1.7M
- XXII 3.6M
- Earning Date
- IDAI 11-14-2025
- XXII 11-11-2025
- Dividend Yield
- IDAI N/A
- XXII N/A
- EPS Growth
- IDAI N/A
- XXII N/A
- EPS
- IDAI N/A
- XXII N/A
- Revenue
- IDAI $3,366,415.00
- XXII $21,362,000.00
- Revenue This Year
- IDAI $25.13
- XXII N/A
- Revenue Next Year
- IDAI $164.45
- XXII $126.57
- P/E Ratio
- IDAI N/A
- XXII N/A
- Revenue Growth
- IDAI N/A
- XXII N/A
- 52 Week Low
- IDAI $1.43
- XXII $1.46
- 52 Week High
- IDAI $18.75
- XXII $469.17
- Technical
- Relative Strength Index (RSI)
- IDAI 64.41
- XXII 42.72
- Support Level
- IDAI $3.50
- XXII $1.46
- Resistance Level
- IDAI $4.07
- XXII $1.60
- Average True Range (ATR)
- IDAI 0.29
- XXII 0.11
- MACD
- IDAI 0.05
- XXII 0.02
- Stochastic Oscillator
- IDAI 66.35
- XXII 27.63
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.